Sugrañes MA, Alvarez PC, Barreto SE, Pérez SM, Hernández VM, Sugrañes MA

Language: Spanish
References: 11
Page: 72-78
PDF size: 95.97 Kb.

ABSTRACT

Background: vernal keratoconjuctivitis is a clinical presentation of ocular allergies. It originates 46 % of ocular allergic processes, with corneal complications involving irreversible visual loss. Objective: to describe a case of vernal keratoconjunctivitis with papillary manifestations. Clinical case: a two-year-old girl is presented with a clinical picture characterized by: conjunctival congestion, lacrimation, secretions, pruritus and photophobia. Despite the treatments received the patient kept the symptoms, that is why she was treated in the Allergy and Ophthalmology consultation at the Pediatric Hospital Eduardo Agramonte Piña. When examining the patient, the doctor found the presence of abundant eye secretions; it was also observed in the cornea a cicatricial lesion of ulcer; papillae had a giant stone-like aspect which was strange because of the age of the patient and the period of evolution of the disease. Both specialists diagnosed vernal keratoconjuctivitis and it was decided an early therapeutic conduct owing to the evolution of the clinical picture and the possible consequences on the vision as a result of the disease.

REFERENCES

1. Gaytán- Melicoff J, Baca-Lozada O, Velazco-Ramos R, Viggiano-Austria D. Comparación entre suero autólogo, clorhidrato de olopatadina y fumarato de ketotifeno, en el manejo de la conjuntivitis alérgica. Rev Mex Oftalmol. 2005;79(1):25-31.

2. Zepeda B, Rosas M, Mitsutoshi F, Del Río E, Sierna J. Conjutivitis alérgica en la infancia. Rev Alergia Mex. 2007;54(2):41-53.

3. Kari O, Matti K. Updates in the treatment of ocular allergies. J asmtha and allergy. 2010;3:149-58.

4. Navarro A. Alergología 2005 Factores epidemiológicos, clínicos y socioeconómicos de las enfermedades alérgicas en España. En: Hernandez AP, editor. Rinitis. Madrid: Luzan 5 S.A. ediciones; 2006. p. 107-32.

5. Ibero M, Castillo MJ, Maseras M. Conjuntivitis alérgica. En: Mendez J, Huerta J, Bellanti JA, Ovilla R, Escobar A, editores. Alergia: Enfermedad Multisistémica. Aspectos básicos y clínicos. 1ª ed. México: Editorial Panamericana; 2008. p. 127-33.

6. Corthany A. How do regulatory T cells work? Scand J Immunol. 2009;70(4):326-36.

7. Cuvilleo A, Sastre J, Montoro J, Jáuregui I, Dávila I, Ferrer M, et al. Allergic conjunctivitis and H1 antihistamines. J Investig Allergol Clin Immunol. 2009;19(1):11-8.

8. Tarrús J, Escala F, Bartra J, Enrique E. Conjuntivitis alérgicas. Badalona: Ediciones médicas, S.L; 2005.

9. Gill D, Tan PH. Induction of pathogenic cytotoxic T lymphocytes tolerance by dendritic cells: a novel therapeutic target. Expert Opin Ther Target. 2010;14(8):797-824.

10. Ibáñez MD, Garde JM. Allergy in patients under fourteen years of age in Alergológica. J Investig Allergol Clin Immunol. 2009;19(2):61-8.

11. Broside DH. Immunomodulation of allergic disease. Annu Rev Med. 2009;60:279-91.